The position of imidazopyridine and metabolic activation are pivotal factors in the antimutagenic activity of novel imidazo[1,2-a]pyridine derivatives
- 1 September 2013
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 715 (1-3), 212-218
- https://doi.org/10.1016/j.ejphar.2013.05.018
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antimutagenic and antioxidant activity of novel 4-substituted phenyl-2,2'-bichalcophenes and aza-analogsDrug Design, Development and Therapy, 2013
- Zolpidem for insomniaExpert Opinion on Pharmacotherapy, 2012
- Synthesis, antibacterial and potential anti-HIV activity of some novel imidazole analogsActa Pharmaceutica, 2011
- Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo[1,2-a]pyridine and imidazo[2,1-b][1,3]benzothiazole motifsEuropean Journal of Medicinal Chemistry, 2011
- Mutagenicity and anti-mutagenicity of Acanthopanax divaricatus var. albeofructusThe Journal of Toxicological Sciences, 2011
- Role of human CYP1A1 and NAT2 in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutagenicity and DNA adductsXenobiotica, 2009
- The antimutagenicity of 2-substituted selenazolidine-4-(R)-carboxylic acidsMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2007
- Heterocyclic amines: Chemistry and healthMolecular Nutrition & Food Research, 2006
- Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agentsBioorganic & Medicinal Chemistry Letters, 2006
- Suicide inhibitors of cytochrome P450 1A1 and P450 2B1Biochemical Pharmacology, 1992